Search Results - "RUDAS, Margarethe"

TP53 Mutation and p53 Overexpression for Prediction of Response to Neoadjuvant Treatment in Breast Cancer Patients by KANDIOLER-ECKERSBERGER, D, LUDWIG, C, JAKESZ, R, RUDAS, M, KAPPEL, S, JANSCHEK, E, WENZEL, C, SCHLAGBAUER-WADL, H, MITTLBÖCK, M, GNANT, M, STEGER, G

“…The value of p53 to predict the cytotoxic effect of two commonly used chemotherapy regimens was assessed in patients with advanced breast cancer. Response to a…”
Get full text

Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cells by Singer, Christian F, Hudelist, Gernot, Fuchs, Eva-Maria, Köstler, Wolfgang, Fink-Retter, Anneliese, Gschwantler-Kaulich, Daphne, Gnant, Michael, Lamm, Wolfgang, Rudas, Margarethe, Czerwenka, Klaus, Kubista, Ernst

“…ERBB2 amplification and consecutive overexpression is a predictor for poor prognosis in breast cancer patients. In addition, incomplete resection of…”
Get full text

Pattern of Hormone Receptor Status of Secondary Contralateral Breast Cancers in Patients Receiving Adjuvant Tamoxifen by BACHLEITNER-HOFMANN, Thomas, PICHLER-GEBHARD, Barbara, JAKESZ, Raimund, RUDAS, Margarethe, GNANT, Michael, TAUCHER, Susanne, KANDIOLER, Daniela, JANSCHEK, Elisabeth, DUBSKY, Peter, ROKA, Sebastian, SPORN, Emanuel

“…In breast cancer patients receiving adjuvant tamoxifen after unilateral treatment, contralateral breast cancer (CBC) is extremely rare. As a result, only…”
Get full text

A Combined High Temporal and High Spatial Resolution 3 Tesla MR Imaging Protocol for the Assessment of Breast Lesions: Initial Results by Pinker, Katja, Grabner, Gunther, Bogner, Wolfgang, Gruber, Stephan, Szomolanyi, Pavol, Trattnig, Siegfried, Heinz-Peer, Gertraud, Weber, Michael, Fitzal, Florian, Pluschnig, Ursula, Rudas, Margarethe, Helbich, Thomas

“…PURPOSE:To develop a 3.0 Tesla breast imaging protocol that combines high temporal and spatial resolution three-dimensional MR sequences for quantitative time…”
Get full text

Towards the Expression of Sex Hormone Receptors in the Human Vocal Fold by Schneider, Berit, Cohen, Eleonore, Stani, Josefine, Kolbus, Andrea, Rudas, Margarethe, Horvat, Reinhard, van Trotsenburg, Michael

“…Summary Background: The human larynx is assumed to be a steroid receptor target organ. There are only very limited data on the evidence of steroid receptors in…”
Get full text

CXCR4 is expressed in ductal carcinoma in situ of the breast and in atypical ductal hyperplasia by SCHMID, Bernd C, RUDAS, Margarethe, REZNICZEK, Günther A, LEODOLTER, Sepp, ZEILLINGER, Robert

“…Recent evidence attributed important influence of chemokines and their receptors on motility, homing, and proliferation of cancer cells at specific metastatic…”
Get full text

Immunohistochemical examinations of sex hormone receptors in benign vocal fold lesions by Cohen, Eleonore, Kolbus, Andrea, van Trotsenburg, Michael, Rudas, Margarethe, Horvat, Reinhard, Schneider, Berit

“…Acquired benign vocal fold lesions are among the most common causes of voice problems. Since the local impact of estrogen and progesterone receptors in…”
Get more information

Preoperative therapy with epidoxorubicin and docetaxel plus trastuzumab in patients with primary breast cancer: a pilot study by WENZEL, Catharina, HUSSIAN, Dagmar, BARTSCH, Rupert, PLUSCHNIG, Ursula, LOCKER, Gottfried J, RUDAS, Margarethe, GNANT, Michael F, JAKESZ, Raimund, ZIELINSKI, Christoph C, STEGER, Guenther G

“…Combining anthracyclines and taxanes are to date the most active cytotoxic treatment option in the neoadjuvant and palliative therapy of breast cancer…”
Get full text

Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor by Wenzel, Catharina, Locker, Gottfried J, Schmidinger, Manuela, Rudas, Margarethe, Taucher, Susanne, Gnant, Michael FX, Jakesz, Raimund, Steger, Guenther G

“…Anthracyclines and taxanes are to date the most active cytotoxic agents in the treatment of breast cancer, and a combination of these is therefore considered…”
Get full text

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patients with breast cancer by WENZEL, Catharina, LOCKER, Gottfried J, PLUSCHNIG, Ursula, ZIELINSKI, Christoph C, RUDAS, Margarethe, OBERHUBER, Gerhard, GNANT, Michael F, TAUCHER, Susanne, JAKESZ, Raimund, STEGER, Guenther G

“…Anthracyclines and taxanes are the most active cytotoxic agents in the treatment of breast cancer. Based on observations with weekly administration of…”
Get full text

Phase I/II trial of weekly epidoxorubicin and docetaxel (wED) in the neoadjuvant and palliative treatment of patientswith breast cancer by Wenzel, Catharina, Locker, Gottfried J, Pluschnig, Ursula, Zielinski, Christoph C, Rudas, Margarethe, Oberhuber, Gerhard, Gnant, Michael F, Taucher, Susanne, Jakesz, Raimund, Steger, Guenther G

“…Abstract Purpose. Anthracyclines and taxanes are the most active cytotoxic agents in the treatment of breast cancer. Based on observations with weekly…”
Get full text

Preoperative second-line chemotherapy induces objective responses in primary breast cancer by Wenzel, Catharina, Locker, Gottfried J, Bartsch, Rupert, Pluschnig, Ursula, Hussian, Dagmar, Zielinski, Christoph C, Rudas, Margarethe, Gnant, Michael F, Jakesz, Raimund, Steger, Guenther G

“…Preoperative chemotherapy in patients with primary breast cancer results in high response rates, allowing breast-conserving surgery in patients primarily not…”
Get full text

Cytogenetic and comparative genomic hybridization findings in four cases of breast cancer after neoadjuvant chemotherapy by Fazeny-Dörner, Barbara, Piribauer, Maria, Wenzel, Catharina, Fakhrai, Negar, Pirker, Christine, Berger, Walter, Sedivy, Roland, Rudas, Margarethe, Filipits, Martin, Okamoto, Ichi, Marosi, Christine

“…To assess a potential common pattern of genetic alterations in chemotherapy-resistant tumors we analyzed four tumors from breast cancer patients (patients 1–4)…”
Get full text

Karyotypic Findings in Two Cases of Male Breast Cancer by Rudas, Margarethe, Schmidinger, Manuela, Wenzel, Catharina, Okamoto, Ichiro, Budinsky, Alexandra, Fazeny, Barbara, Marosi, Christine

“…Male breast cancer is uncommon; so far, only 10 cases with chromosome banding analysis have been published. We report the cytogenetic findings of two invasive…”
Get full text

Kann man einer hochselektionierten Patientinnengruppe nach brusterhaltender Therapie wegen Mammarkarzinoms die postoperative Nachbestrahlung ersparen? by Grünberger, Th, Gorlitzer, M., Soliman, Th, Rudas, Margarethe, Mittlböck, Martina, Götzinger, P., Gnant, M., Reiner, Angelika, Teleky, B., Seitz, W., Jakesz, R.

Get full text

Eingeladene Kommentare und Schlußwort der Autoren zu:Th. Grünberger, M. Gorlitzer, Th. Soliman, Margarethe Rudas, Martina Mittlböck, P. Götzinger, M. Gnant, Angelika Reiner, B. Teleky, W. Seitz undR. Jakesz: „Kann man einer hochselektionierten Patientinnengruppe nach brusterhaltender Therapie wegen Mammakarzinoms die postoperative Nachbestrahlung ersparen? by Grünberger, Th, Gorlitzer, M., Soliman, Th, Rudas, Margarethe, Mittlböck, Martina, Götzinger, P., Gnant, M., Reiner, Angelika, Teleky, B., Seitz, W., Jakesz, R.

Get full text